Intermittent androgen suppression

被引：16
作者：
Pether, M [1 ]
Goldenberg, SL [1 ]
机构：
[1] Univ British Columbia, Dept Surg, Div Urol, VGH,Prostate Ctr, Vancouver, BC V6T 1W5, Canada
来源：
BJU INTERNATIONAL | 2004年 / 93卷 / 03期
关键词：
prostate cancer; androgens; intermittent therapy; outcome; survival;
D O I：
10.1111/j.1464-410X.2004.04597.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 261
页数：4
相关论文
共 36 条
[21]   Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy [J].
July, LV ;
Akbari, M ;
Zellweger, T ;
Jones, EC ;
Goldenberg, SL ;
Gleave, ME .
PROSTATE, 2002, 50 (03) :179-188
[22]  
KLOTZ LH, 1986, CANCER, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO
[23]  
2-N
[24]  
MCDONNELL TJ, 1992, CANCER RES, V52, P6940
[25]  
MESSING EM, 1998, NEW ENGL J MED, V186, P63
[26]  
NOBLE RL, 1977, CANCER RES, V37, P82
[27]  
Pether Michael, 2003, Can J Urol, V10, P1809
[28]   A 10-year clinical experience with intermittent hormonal therapy for prostate cancer [J].
Prapotnich, D ;
Fizazi, K ;
Escudier, B ;
Mombet, A ;
Cathala, N ;
Vallancien, G .
EUROPEAN UROLOGY, 2003, 43 (03) :233-239
[29]  
RUSSO P, 1987, CANCER RES, V47, P5967
[30]  
Sato N, 1997, CANCER RES, V57, P1584
1234